CN Patent

CN103705521A — 一类治疗脑梗塞的化合物及其用途

Assigned to Individual · Expires 2014-04-09 · 12y expired

What this patent protects

本发明公开了一类化合物及其药物组合物和新用途，所述新用途为在制备治疗脑梗塞的药物中的用途。上述化合物治疗脑梗塞能够达到作用非常显著的效果。

USPTO Abstract

本发明公开了一类化合物及其药物组合物和新用途，所述新用途为在制备治疗脑梗塞的药物中的用途。上述化合物治疗脑梗塞能够达到作用非常显著的效果。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN103705521A
Jurisdiction: CN
Classification: —
Expires: 2014-04-09
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.